ABSTRACT
The telomeric survival motor neuron (SMNT gene is a valuable molecular diagnostic tool for childhood-onset spinal muscular atrophy (SMA) as homozygous deletions of SMNT exon 7 (Δ7SMNT) are present in ∼94% of patients. In this report, we provide the first comprehensive study of 32 unrelated non-deletion SMA patients. Quantitative polymerase chain reaction (PCR) studies established that 90% had two intact copies of SMNT exon 7 suggesting that that these patients do not have 5q SMA. Once 5q SMA is confirmed, the SMNT gene can be screened for subtle mutations. Using single strand conformation analysis, we identified two missense mutations (P245L and Y272C) in exon 6 of the SMNT gene of two SMA patients shown to have a single copy of SMNT exon 7. Y272 is most likely critical for SMNT function as it is target for recurring mutations and is associated with type I SMA. These results emphasize the need for dosage analysis in the differential diagnosis of 5q SMA in non-deletion patients, consistent with extensive clinical heterogeneity and some genetic heterogeneity in this disease. Homozygosity or heterozygosity for a Δ7SMNT allele confirms the diagnosis of 5q SMA with greater precision than clinical examination alone.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received July 14, 1997; Revised and Accepted July 15, 1997
Rights and permissions
About this article
Cite this article
Rochette, C., Surh, L., Ray, P. et al. Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7. Neurogenetics 1, 141–147 (1997). https://doi.org/10.1007/s100480050021
Issue Date:
DOI: https://doi.org/10.1007/s100480050021